ClinicalTrials.gg
Active, not recruitingNCT05543889Updated Feb 23, 2024

Evaluation of Clinical Decisions and Assessment of Those at Risk of Primary Angle Closure by Community Optometrists

An observational study in Angle Closure Glaucoma, sponsored by Moorfields Eye Hospital NHS Foundation Trust. Active, not recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-23.

Sponsored by Moorfields Eye Hospital NHS Foundation Trust · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2024, 2 years 8 months ago, but the record still lists the study as active, not recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
163
Ages
18 Years and older
Sex
All
01

Study summary

Increases in the aging population has resulted in increased demand for glaucoma services. Glaucoma is a disease that if untreated, can lead to blindness. This increase and need for long term treatment with monitoring have resulted in a significant demand in the hospital eye service (HES). Many departments are now facing a considerable backlog of outpatient appointments and it's essential that these appointments are reserved for patients who are at risk of glaucoma blindness.

Primary angle closure (PAC) glaucoma is a type of glaucoma, where the drainage route for the fluid inside the eye (known as the angle) is narrowed or blocked. It has been recently identified that approximately half of patients referred into the HES for a suspect narrow angle for further investigation are healthy and are immediately discharged. The exact reasons for these findings are unknown.

This project will investigate clinical decisions by community optometrists who account for the majority of PAC referrals into the HES, as well as assessing their ability to evaluate those at risk of PAC. This project will also examine whether clinical agreement could be improved by providing an educational package.

A clinical image database of angles will be acquired from glaucoma patients attending Moorfields Eye Hospital. A learning package discussing angle closure referral will also be developed. Community optometrists will be invited to complete a questionnaire on their clinical decision making. This will be followed by the vignette assessment, learning package and re-assessment.

If this educational package and/or any other identifiers are found to improve agreement levels, this could reduce the number of referrals and enable community monitoring of those at low risk of developing PAC glaucoma in their lifetime.

02

Conditions studied

  • Angle Closure Glaucoma

Keywords

  • Limbal anterior chamber depth
  • Optometrist
  • Angle-closure
  • Van Herick
03

In context

Glaucoma, Angle-Closure

91 studies on the registry are indexed under Glaucoma, Angle-Closure; 17 are open to participants now.

This study's enrollment of 163 is below the median of 225 across 32 observational studies indexed under Glaucoma, Angle-Closure.

Browse Glaucoma, Angle-Closure studies →

Lead sponsor

Moorfields Eye Hospital NHS Foundation Trust is the lead sponsor of 48 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

New patients to the glaucoma service will be selected as they would be a real-world reflection of those who have been identified at risk of developing glaucoma that have been referred for glaucoma investigation within the hospital eye service from primary care. Furthermore, they would have an enriched sample of narrow angles that are required to achieve the desired the case-mix required for the image database within the set timelines.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

New patients attending the glaucoma clinic at Moorfields Eye Hospital

Exclusion criteria

Exclusion Criteria:

  • They cannot be examined using a table mounted slit lamp due to physical limitations or have gross nystagmus.
  • Unable to consent
  • If they are unable to communicate in English and there is no available interpreter that meets requirements set out by Moorfields standard operating policies for patients
  • Under 18 years old
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
163 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients

    100 patient participants will be recruited for limbal anterior chamber depth image capture. These images will be used to develop the clinical vignette database

  • Optometrists

    50 optometrists will be recruited to undertake the clinical vignette assessment

    Other: Educational package

Interventions

  • OtherEducational package

    Online learning package that will discuss the van Herick technique, grading, accuracy and information and discusses the current guidelines for primary angle closure suspect referral.

06

What researchers measure

Primary outcomes

  1. Agreement of community optometrists on measuring Limbal anterior chamber depth

    Levels of agreement and precision of optometrist observers before and after intervention of online educational package in assessment of Limbal anterior chamber depth as a surrogate measure of angle width. Agreement will be measured via an online assessment vignette assessment package. Weighted Kappa statistic and levels agreement will be the outcome measures

    Time frame: 12 months

Secondary outcomes

  1. Qualitative outcome measures from optometrists

    Questionnaire based outcomes capturing data around current practice, qualifications and training, knowledge and resources available in practice with regards to angle closure diagnosis and referral

    Time frame: 12 months

  2. Qualitative outcome measures from patients

    Difficulty in performing tests and satisfaction from the appointment (Likert scale 1-10), time taken (minutes) and costs of travel (£) to test site and waiting time to be examined from referral (months).

    Time frame: 12 months

07

Study locations

1 site
  • Moorfields Eye Hospital NHS Foundation Trust, 162 City Road
    London, EC1V 2PD, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2022 (actual). Primary completion is estimated for Mar 2024, 15 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 13, 2022
First posted
Sep 16, 2022
StartActual
Dec 7, 2022
Primary completionEst.
Mar 7, 2024
CompletionEst.
Mar 7, 2024
Last update
Feb 23, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05543889
Lead sponsor
Moorfields Eye Hospital NHS Foundation Trust
Responsible party
Sponsor
First posted
Sep 16, 2022
Start date
Dec 7, 2022
Primary completion
Mar 7, 2024 (estimated)
Completion
Mar 7, 2024 (estimated)
Last update
Feb 23, 2024

Study contacts

Anish Jindal
principal investigator · Moorfields Eye Hospital NHS Foundation Trust/UCL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion